Priorities for Hepatocellular Carcinoma (HCC) Control

A Comparison of Policy Needs in Five European Countries

Datos Bibliográficos

ID12626098
AutoresJohn F P Bridges (0000-0002-3082-5535, Johns Hopkins University, autor de correspondencia), Susan M Joy (Johns Hopkins University), Gisselle Gallego (0000-0002-3243-8176, Johns Hopkins University), Barri M Blauvelt (University of Massachusetts Amherst), J F Geschwind (Johns Hopkins Hospital), Jean-Francois H Geschwind, Timothy M Pawlik (0000-0002-7994-9870, Johns Hopkins Hospital)
Año2012
Volumen14
Número4
Páginas352-368
Fecha de publicación2012-08-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaJournal of Comparative Policy Analysis Research and Practice (JOURNAL)
Identificadores de la revistaISSN: 1387-6988 • E-ISSN: 1572-5448
EditorialRoutledge (PUBLISHER • GB)
DOI10.1080/13876988.2012.698581
OpenAlexW2006539023
IdiomaEN
Citas recibidas1
Referencias citadas42

In 2006, the European Parliament designated hepatocellular carcinoma (HCC) a serious public health problem, recognizing it as both a complex and deadly cancer. The authors conducted the first comparative needs assessment for HCC across five European countries. One hundred HCC experts assessed ten dimensions of HCC control. Common needs exist for lifestyle risk factor management (p < 0.001), political awareness (p < 0.001) and public awareness (p < 0.001). Discordances were found on funding for treatment (p = 0.001) and screening (p = 0.006), hepatitis C (p = 0.035), and hepatitis B (p = 0.050) strategies. The findings identify the priority needs, both common and country-specific, that should be addressed in these countries

Environmental health · Family medicine · Hepatocellular carcinoma · Liver cancer · Parliament · Pathology · Political science · Politics · Public health · Economic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Hepatocellular Carcinoma Treatment and Prognosis · Medicine · Gastroenterology · Internal Medicine